Publication | Closed Access

Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome

Cardiorenal Anemia SyndromeCardiorenal SyndromesCardiovascular Diseaseβ-Erythropoietin TreatmentHematologyCardiovascular PharmacologyDiuretic ResistanceLeft Ventricular RemodelingCardiovascular FunctionMedicineCardiologyDiastolic FunctionEmergency MedicineAnesthesiology